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Abstract
Background: The aim of this study was to analyse the role of GM allotypes, i.e. the hereditary antigenic determinants
expressed on immunoglobulin polypeptide chains, in the attainment of longevity. The role played by immunoglobulin
allotypes in the control of immune responses is well known as well as the role of an efficient immune response in
longevity achievement. So, it is conceivable that particular GM allotypes may contribute to the generation of an
efficient immune response that supports successful ageing, hence longevity.
Methods: In order to show if GM allotypes play a role in the achievement of longevity, we typed the DNA of 95 Long-
living individuals (LLIs) and 96 young control individuals (YCs) from South Italy for GM3/17 and GM23+/− alleles.
Results: To demonstrate the role of GM allotypes in the attainment of longevity we compared genotype and allele
frequencies of GM allotypes between LLIs and YCs. A global chi-square test (3 × 2) shows that the distribution of
genotypes at the GM 3/17 locus is highly significantly different in LLIs from that observed in YCs (p < 0.0001). The 2 × 2
chi-square test shows that the carriers of the GM3 allele contribute to this highly significant difference. Accordingly, GM3
allele is significantly overrepresented in LLIs. No significant differences were instead observed regarding GM23 allele.
Conclusion: These preliminary results show that GM3 allotype is significantly overrepresented in LLIs. To best of our
knowledge, this is the first study performed to assess the role of GM allotypes in longevity. So, it should be necessary to
verify the data in a larger sample of individuals to confirm GM role in the attainment of longevity.
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Background
The term allotype refers to any genetic variant of a pro-
tein. However, in immunology it is used for hereditary
antigenic determinants expressed on immunoglobulin
polypeptide chains, i.e. the genetic markers of γ chains
(GM). GM allotypes are encoded by autosomal codomi-
nant alleles that follow Mendelian laws of heredity on
immunoglobulin heavy chain γ1, γ2 and γ3 genes [1].
The role played by immunoglobulin allotypes in the con-
trol of immune responses was recognized 46 years ago
[2]. Several studies have clearly shown that immune
response to many infectious agents, vaccines, and auto-
antigens is associated with particular GM allotypes [3].
Moreover, the well-known differences in the frequencies
of GM allotypes among different ethnic groups, and the
strong linkage disequilibrium within a given ethnic
group, suggest that Darwinian selection over many
generations, i.e. selection by major infectious diseases,
has played a role in the maintenance of polymorphisms
of IGHG genes, of which some are common and others
are rare [3].
On the other hand, the role of an efficient immune re-
sponse in the attainment of longevity is well known [4];
hence it is reasonable to hypothesize an association of
GM allotypes with longevity. Using hypothesis driven
candidate gene approaches, numerous studies have
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identified particular GM genes as risk factors for many
malignant, infectious, and autoimmune diseases, but
most of these findings have not been confirmed or
refuted by the genome-wide association studies (GWAS)
[3]. In addition, GWAS on longevity have not demon-
strated associations of these genotypes with longevity. In
fact, although most GM alleles are common within an
ethnic group (some with gene frequency > 70%), they are
not being evaluated in the GWAS of longevity, because
these determinants are not included in the commonly
employed genotyping platforms. In fact, since GM allo-
types were not typed in the haplotype map (HapMap)
project, they cannot be imputed. Even in the 1000
Genomes project, the coverage of this region is very low,
resulting in poor quality of imputation [5].
Therefore, a candidate gene approach is necessary for
evaluating the possible role played by GM genes in the
attainment of longevity. So, in this paper we have ana-
lysed, by classic case control study, the distribution GM
allotypes in longevous people and controls from South-
ern Italy. To this end, we analysed the frequencies of
GM3 and GM17 determinants (arginine to lysine
replacement) expressed in the constant heavy (CH)1 re-
gion of IgG1 heavy chain, and GM23- and GM23+
determinants (valine to methionine replacement) in the
fragment crystallisable region (Fc) of IgG2 heavy
chain [1, 3].
Results
In order to demonstrate the role of GM allotypes in the
attainment of longevity and to strengthen previous
results suggesting that genetic factors involved in im-
mune responses may play a key role in longevity, we
compared genotype and allele frequencies of GM allo-
types between LLIs and YCs.
The genotype frequency distributions of GM3/17
genotypes and alleles are presented in Tables 1 and 2,
respectively. A global chi-square test (3 × 2) shows that
the distribution of the three genotypes at the GM 3/17
locus is highly significantly different in LLIs from that
observed in YCs (p < 0.0001). The 2 × 2 chi-square test
shows that the carriers of the GM3 allele contribute to
this highly significant difference. Accordingly, GM3 al-
lele is significantly overrepresented in LLIs (Table 2)
(OR = 2.13; P = 0.0003).
Since it is well known that immune system ages differ-
ently in males and females [6], we analysed data separ-
ately for men and women. Results show that GM3 allele
is significantly associated with longevity in both the
sexes (data not shown).
The genotype frequency distributions of GM23 geno-
types and alleles are presented in Tables 3 and 4, re-
spectively. No significant differences were found for the
distribution of GM23 genotypes and alleles between LLIs
and YCs. Also, analysing data according to sexes, no
significant differences were found in both males and
females (data not shown).
Discussion
The LLIs, i.e. those approaching 100 years of age, are a
model of successful ageing. The exceptional longevity of
LLIs is to some extent genetically guided, as emphasized
by the family clustering of extreme longevity and the re-
duced mortality of the centenarian siblings compared to
age-related elderly [7]. Longevity genes can be discov-
ered by genetic association studies or GWAS conducted
on LLIs [7, 8]. These kinds of studies identify the gene
variants that have been selected by the demographic
pressure and, therefore, are somehow significant for hu-
man health. The identification of these genetic variants is
important since they could represent potential targets for
fighting ageing-related diseases. Several research groups
are working on genes involved in oxidative stress, in lipid
and glucose metabolism, in immune-inflammatory re-
sponses, in DNA damage and in repair, in nutrient sensing
pathways. Many results have been obtained in association
studies of candidate genes, but other results are still in
conflict. In particular, to date, the majority of GWAS, that
rely on large population sets for multiple testing and
power issues, have only confirmed the decreased
Table 1 GM 3/17 genotypes in 95 Long-living individuals (LLIs)
and Controls (YCs)
LLI s YCs Chi square P
GM 3/3 48 17 18.99 0.00001
Rest 47 70
Total 95 87
LLI Controls Chi square P
GM 3/17 37 57 12.83 0.0003
Rest 58 30
Total 95 87
LLI Controls Chi square P
GM 17/17 10 13 0.802 0.3704
Rest 85 74
Total 95 87
3/3 genotype OR (C.I. 2.16–8.18) = 4.21 (P < 0.00001)
Table 2 GM 3/17 Alleles in Long-living individuals (LLIs) and
Controls (YCs)
N = 190 N = 174 OR C.I. p
LLIs YCs
+ % + %
3 133 70 91 52 2.13 1.38–3.27 =0.0003
17 57 30 83 48
Significance of distribution by chi square test (2 × 2) p = 0.0005
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frequency of detrimental alleles of apolipoprotein E
(APOE) and the increase of protective alleles of forkhead
box O3A (FOXO3A) with some exceptions [7–10].
In the present paper we have analysed, by a classic
case control study, the distribution of GM allotypes, in
longevous people and controls from Southern Italy. Data
show that GM3 allotype is significantly overrepresented
in LLIs. To the best of our knowledge, no study has
evaluated GM allotype role in human longevity. Since
the distribution of GM allotypes in the population under
study is not known, a note of caution must be taken into
account, because of the relatively small sample sizes of
LLIs and controls. However, a study performed on the
sheep several years ago reported an influence of IgG3 al-
lotypes in ageing of sheep. These findings, showing the
role played by GM allotypes in other animal species, fit
ours [11].
A study by de Vries et al. [12] is relevant to our find-
ings. Descendants of Dutch colonists, who emigrated to
Surinam and survived epidemics of typhoid and yellow
fever with a total mortality of about 60%, were tested for
different polymorphisms, including GM allotypes, whose
frequencies were compared with those of Dutch control
sample. Several polymorphisms, including GM allotypes,
were shown to influence the chance for survival, indicat-
ing selection through genetic control of immune
response to pathogens. Another example of such selec-
tion is the longevity associated variant of Bactericidal/
Permeability-increasing (BPI) Family B member 4
(BPIFB4), which belong to a family of proteins, BPI and
lipid transfer protein (LTP), involved in the activation
of toll-like receptor(TLR)-4 in the innate immune re-
sponse [13].
So, it is conceivable that particular GM allotypes may
contribute to the generation of a dynamic immune
response that supports successful ageing, hence longevity,
whereas certain other allotype combinations may produce
suboptimal levels of immunity and reduced life span.
In particular, GM allotypes have been shown to be in-
volved in the immunological control of viruses, including
herpes simplex virus(HSV)-1 and human cytomegalovirus
(HCMV) [14, 15]. Herpes viruses, such as HCMV and
HSV-1, have been associated with a variety of health prob-
lems, including cognitive decline, and overall mortality in
the elderly [16–19]. Accordingly, recent data show that ef-
fective control of herpes viruses is impaired during healthy
ageing, most probably due to loss of cellular control of
early viral reactivation [20–22].
Recently, an interplay between particular GM and cluster
of designation(CD)16A alleles in the outcome of HSV-1
infection has been demonstrated. The CD16A-158 V/V
genotype associates with an asymptomatic course of
HSV-1 infection only in homozygotes for the GM3 allele.
Additional studies to determine the mechanism underlying
this association showed that CD16A-158 V and GM3
alleles epistatically enhanced the antibody-dependent
cell-mediated cytotoxicity (ADCC) against opsonized
HSV-1-infected fibroblasts [14].
Concerning HCMV, in different populations it has
been demonstrated the association of human IgG1 allo-
types with immune response to the virus and some kinds
of cancer thought to be associated with HCMV [23, 24].
More interestingly, in another Southern Italy population,
GM17/17 (the alternative allele of GM3) was associated
with the risk of developing HCMV symptomatic infec-
tion [15]. It is well known the role of chronic infections
from herpes viruses, in particular from HCMV, in the
impairment of immune responses of elderly people,
hence contributing to immunosenescence [25, 26].
Accordingly, the severity of many infections is higher in
the elderly compared to younger adults and infectious
diseases are frequently associated with frailty and death.
Reciprocally, an immune good function is tightly corre-
lated to health status and longevity [4, 27–29].
On the other hand, our immune system is known to be
quite efficient in fighting acute infections in young people,
but not particularly efficient in responding to chronic
stimuli, especially when they occur late in life. This leads to
an increased production of inflammatory mediators.
So, this chronic antigenic stress contributes to deter-
mine an inflammatory status called inflamm-ageing,
responsible for age-related diseases. Reciprocally, the
control of inflamm-ageing is associated with longevity
[4, 30–33]. Accordingly, an efficient control of Herpes
Virus chronic infections by GM allotypes might con-
tribute to observed association with longevity through
a decrease of inflammatory status.
Table 3 GM 23 genotypes in Long-living individuals (LLIs) and
Controls (YCs)
N = 96 N = 92
LLIs YCs
+ – % + – %
23 −/− 20 76 20.8 18 74 19.6
23 +/− 38 58 39.6 39 53 42.4
23 +/+ 38 58 39.6 35 57 38.0
Significance of distribution by chi square test (2 × 6) p = NS
Table 4 GM 23 Alleles in Long-living individuals (LLIs) and
Controls (YCs)
N = 192 N = 184
LLIs Controls
+ % + %
23 + 114 59.4 109 59.2
23 - 78 40.6 75 40.8
Significance of distribution by chi square test (2 × 2) p = N.S
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Several mechanisms have been proposed to explain
the role played by GM allotypes in the control of
virus infections. IgG allotypes might modulate avidity
of the interaction of IgG with Fcγ receptor (FcγR), so
influencing the efficacy of immune response. In
addition, they might modulate the strength of ADCC,
thus involving cells of innate response such as natural
killer (NK) cells [2, 3].
Conclusion
This is the first report implicating GM allotypes in longev-
ity. It needs to be replicated in an independent and larger
multi-ethnic study population. However, it has been
reported that the association with longevity of other genes
related to control of immune response as human
leukocyte antigens (HLA) and killer immunoglobulin-like
receptors (KIR), is population specific, being heavily
affected by the population-specific genetic and environ-
mental history [34]. On the other hand, it is also possible
that there are other life span-associated loci on chromo-
some 14q32 (where the GM genes are located), distinct
from GM, whose alleles are in significant linkage disequi-
librium with those of the GM loci. This putative linkage
disequilibrium could give rise to the associations observe.
Methods
We genotyped 96 Long-living individuals (LLIs) (40 fe-
male, mean age 96.7, age-range 91–104; 56 male, mean
age 93.6, age range 90–104 years) and 96 young control
individuals (YCs) (66 female, mean age 31.9, age-range
20–44; and 30 male, mean age 35.2, age range 23–
45 years) already recruited as part of the Southern Ital-
ian Centenarian Study [35]. The LLIs were thoroughly
investigated for demographic characteristics, medical
history (past and present diseases), level of independence
and cognitive status. All subjects donated blood samples
for DNA study and gave written informed consent to
the study, which was approved by Ethical Committee of
Salerno University. All methods were performed in
accordance with the relevant guidelines and regulations.
The study was conducted in accordance with the ethical
principles that have their origins in the Declaration of
Helsinki.
DNA was obtained from peripheral blood leukocytes
by the salting-out technique and stored until the use.
For the determination of GM3 and GM17 allotypes (A
to G substitution), a direct DNA sequencing method,
Sanger sequencing, was used. The DNA segment encod-
ing the CH1 region of γ1 chain was amplified by poly-
merase chain reaction (PCR) according to Balbìn et al.,
[36] using the following primers: 5’ CCCCTGGCA
CCCTCCTCCAA 3′ and 5’ GCCCTGGACTGGGG
CTGCAT 3′. The purified double-stranded PCR product
(364 bp) was subjected to automated DNA sequencing
on an ABI PRISM 3730xl DNA Analyzer. IgG2 markers
GM 23− and 23+ (a G to A substitution in the Fc of the
γ2 chain) were genotyped by a nested PCR-restriction
fragment length polymorphism(RFLP) method [37].
IgG3 markers GM5 and GM21 were not typed, because
TaqMan genotyping assays for the IgG3 allotypes are
not yet available. Due to technical problems, it was not
possible to type for GM3/17 one LLI and nine YCs and
fror GM23 four YCs. Because of almost absolute linkage
disequilibrium at GM loci within an ethnic group, sub-
jects positive for the IgG1 allotypes GM3 and GM17 are
most likely positive for the IgG3 allotypes GM5 and
GM21 (Pandey, unpublished observations).
Allele and genotype frequencies among groups were
estimated by gene counting. The different chi-squares
tests were used to detect significant changes in genetic
variables between groups where appropriate. Standard
odds ratios (OR) with 95% confidence interval (CI) were
calculated.
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